Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @DrugInfoAssn
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @DrugInfoAssn
-
What lessons can be learned from PerfO assessments, and how can this help establish content validity in patient-reported outcome measurement in clinical trials? Let’s talk about meaningfulness of technology-driven measures! http://ow.ly/BQw750yeBE8 pic.twitter.com/rQjzj5cn1B
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
[Sponsored] Running clinical trials is expensive! Speed up the process by using
@ArriaNLG AI technology to intelligently automate the analysis of clinical data#bigdata#technology#arrianlg Ready to see Arria in action? Request a demo now!http://ow.ly/NnQy50y25LfHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
If you work in Pharmacovigilance, explore our partnership with the
#PRAC Chair, the Dutch Medicines Evaluation Board! Join our Content Preview Webinar on 13 February 9AM CET to ask questions and learn about the most comprehensive PV Course in Europe! http://ow.ly/BTqo50yea5Z pic.twitter.com/2WNG1iJXZW
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In six days, Ashley Brown will share her story. Join DIA at
#RSIDM20 for "A New Passion to Life: Experiencing the Impact of Regulatory Submissions". You'll be glad you did! http://ow.ly/WNYx50ydAQJ pic.twitter.com/xFGyxXNRE6
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
[Sponsored] Adis Pharmacovigilance is the expert solution for regulatory literature monitoring, from the industry-leading provider of drug safety and pharmacovigilance content. Find out more on how Adis can partner with you here: http://bit.ly/37B4Yum
#PVRMS20pic.twitter.com/PXET02tagb
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Starting in 30 minutes! Gain insight into FDA's final guidance on Adaptive Design
#ClinicalTrials for Drugs and#Biologics! http://ow.ly/Xb6C50yadxT pic.twitter.com/9ANsYO5tYx
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
This March 17 in Brussels, the DIAmond Session on Shortages will see the EU Commission, Regulators, NGOs & Industry experts debate drug shortages, exploring causes & solutions! Session chairs Kristin Raudsepp & Thomas Senderovitz await you at DIA Europe: http://ow.ly/GbpB50ya7uD pic.twitter.com/r6wEg6F2md
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
How do regional trends in
#labeling differ? Get prepared and understand present audit expectations of#regulatory authorities! In just one hour, you'll review recent audit observations and discuss best preparation practices. http://ow.ly/EZgr50yckgM pic.twitter.com/7Ey82f42vj
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Meet leading regulators and industry experts in London at the Pharmacovigilance Strategies Workshop, which provides guidance and practical recommendations to adopt to the changing Pharmacovigilance landscape in Europe. Early Bird Rates end February 11! http://ow.ly/E98v50ya6kz pic.twitter.com/uvanSErY8i
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Novel coronavirus originating in China has already spread to several continents, raising global fear of cases emerging in more countries. Where can you learn more about global disease outbreaks? http://ow.ly/d6Xo50y9uKu pic.twitter.com/UcVZNo6aZL
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Get involved in
#DIA2020 by submitting a poster abstract during our Call for Professional & Student Posters! This is you opportunity to get your research, best practices, and lessons learned in front of the right audience. The deadline is Feb 13! http://ow.ly/9UeD50ya6OA pic.twitter.com/17zUBBnDY4
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Get an overview of recent regulatory efforts in the area of Complex Innovative Trial Designs, including insight into FDA's final guidance on Adaptive Design
#ClinicalTrials for Drugs and#Biologics! What can you learn in one hour? http://ow.ly/cQUq50yadbZ pic.twitter.com/k9KFhtVHte
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
This course will explore how RWE can be harnessed to measure outcomes & better understand the price, value, and impact of next generation therapies. Join us to discuss creative pricing solutions towards improving patient access to new treatment classes: http://ow.ly/hRYl50y9t7Q pic.twitter.com/jJQJtllfXn
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Novel coronavirus originating in China has already spread to several continents, raising global fear of cases emerging in more countries. Where can you learn more about global disease outbreaks? http://ow.ly/d6Xo50y9uKu pic.twitter.com/INMiOt2ZfG
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Coming to
#LARC20 in Miami: Regulators and industry professionals from 12 American nations, the EU, and...you? Advance rates end tonight, 1/30! http://ow.ly/uAtT50y9pPQ pic.twitter.com/DGDUtH3NL2
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
[Sponsored] Live at 11 AM! Join CitiusTech and DIA for a look at data management and compliance challenges w/varying State Drug Price Transparency Laws & approaches for manufacturers to effectively & efficiently manage complex reporting processes. http://ow.ly/6R3o50y5TVI pic.twitter.com/1hQoXRVwyM
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
FDA's Patient-Focused Drug Development (PFDD) Guidances will impact Marketing Strategies for
#MedicalProducts. What are they and where can you learn more? Click to view!#AdPromo#DrugDevelopment http://ow.ly/dXHy50y94zZ pic.twitter.com/JF65nu7S9b
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
How are Pharmaceutical
#pricing & reimbursement policies developing? How is the use of HTA evolving? Companies should address recent developments by reinforcing their market access capabilities. This Training Course is a great place to get started: http://ow.ly/b0Pv50y8Gjx pic.twitter.com/JQW9I2xND6
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
DIA proslijedio/la je Tweet
Howard Chazin, OGD, FDA, shares proactive safety surveillance of complex generic drug-device combo prods at
#PVRMS20.pic.twitter.com/YUEmIiUgGL
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Join Gautam Gulati, MD, for 3 meetings in 1! The DIA Medical Affairs and Scientific Communications Forum features crosscutting plenary sessions and
#medcomm, medical writing, and MSL tracks. Follow one or create your own! Early Bird Rates end 1/30! http://ow.ly/9pCO50y8sc8 pic.twitter.com/WKe924ex2b
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.